Pedro J. Lasanta - 06 Mar 2023 Form 4 Insider Report for Pharma-Bio Serv, Inc. (PBSV)

Role: Chief Financial Officer
Signature: /s/ Pedro J. Lasanta
Issuer symbol: PBSV
Transactions as of: 06 Mar 2023
Net transactions value: -$0.6
Form type: 4
Filing time: 08 Mar 2023, 15:23:24 UTC
Previous filing: 13 Dec 2021
Next filing: 28 Dec 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PBSV	Common Stock	Options Exercise	$88,000	+100,000	+106%	$0.8800	194,552	06 Mar 2023	Direct
transaction	PBSV	Common Stock	Tax liability	$88,000	-76,522	-39%	$1.15	118,030	06 Mar 2023	Direct	F1
transaction	PBSV	Common Stock	Options Exercise	$8,242	+8,325	+7.1%	$0.9900	126,355	06 Mar 2023	Direct
transaction	PBSV	Common Stock	Tax liability	$8,242	-7,167	-5.7%	$1.15	119,188	06 Mar 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PBSV	Stock Option	Options Exercise	$0	-100,000	-100%	$0.000000^*	0	06 Mar 2023	Common Stock	100,000	$0.8800	Direct	F2
transaction	PBSV	Stock Option	Options Exercise	$0	-8,325	-33%	$0.000000	16,675	06 Mar 2023	Common Stock	8,325	$0.9900	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the aggregate amount of shares of Common Stock withheld for a cashless exercise.
F2	The stock option vested in three equal annual installments beginning on October 4, 2020.
F3	On December 9, 2021, the reporting person was granted a stock option to purchase 25,000 shares, which stock option vests in three equal installments beginning on December 9, 2022.